{"Title": "Brentuximab vedotin prior to allogeneic stem cell transplantation in Hodgkin lymphoma: a report from the EBMT Lymphoma Working Party", "Year": 2018, "Source": "Br. J. Haematol.", "Volume": "181", "Issue": 1, "Art.No": null, "PageStart": 86, "PageEnd": 96, "CitedBy": 13, "DOI": "10.1111/bjh.15152", "Link": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85042323289&origin=inward", "Abstract": "\u00a9 2018 John Wiley & Sons LtdBrentuximab vedotin (BV) is an anti-CD30 antibody-drug conjugate. Preliminary data suggest that BV might improve outcomes after allogeneic stem cell transplantation (SCT) for Hodgkin lymphoma (HL) when used as pre-transplant salvage therapy. Between 2010 and 2014, 428 adult patients underwent an allogeneic SCT for classical HL at participating centres of the European Society for Blood and Marrow Transplantation. We compared the outcomes of 210 patients who received BV prior to allogeneic SCT with that of 218 patients who did not receive BV. The median follow-up for survivors was 41 months. Patients in the BV group were more heavily pre-treated (median pre-allograft treatment lines: 4 vs. 3). The two groups were comparable in terms of disease status, performance status, comorbidities, prior autologous SCT, type of donor, conditioning and in vivo T cell depletion. In multivariate analysis, pre-allograft BV had no impact on acute graft-versus-host disease (GVHD), non-relapse mortality, cumulative incidence of relapse, progression-free survival or overall survival (OS), but significantly reduced the risk of chronic GVHD (hazard ratio = 0\u00b764; 95% confidence interval = 0\u00b745\u20130\u00b792; P < 0\u00b702). Older age, poor performance status, use of pre-transplant radiotherapy and active disease at SCT adversely affected OS. Patients allografted for HL after prior exposure to BV do not have a superior outcome after allogeneic SCT except for a lower risk of chronic GVHD. However, BV may improve the outlook of allogeneic SCT by helping otherwise refractory patients to achieve a more favourable disease status, facilitating allotransplant success.", "AuthorKeywords": ["allogeneic stem cell transplant", "Hodgkin lymphoma", "salvage therapy", "stem cell transplantation"], "IndexKeywords": ["Adolescent", "Adult", "Aged", "Allografts", "Disease-Free Survival", "Female", "Follow-Up Studies", "Hematopoietic Stem Cell Transplantation", "Hodgkin Disease", "Humans", "Immunoconjugates", "Male", "Middle Aged", "Survival Rate"], "DocumentType": "Journal", "PublicationStage": null, "OpenAccess": 1, "EID": "2-s2.0-85042323289", "SubjectAreas": [["Hematology", "MEDI", "2720"]], "AuthorData": {"7006517199": {"Name": "Bazarbachi A.", "AuthorID": "7006517199", "AffiliationID": "60068761", "AffiliationName": "Department of Internal Medicine, American University of Beirut"}, "57190088309": {"Name": "El-Cheikh J.", "AuthorID": "57190088309", "AffiliationID": "60068761", "AffiliationName": "Department of Internal Medicine, American University of Beirut"}, "6506480736": {"Name": "Boumendil A.", "AuthorID": "6506480736", "AffiliationID": "60009907", "AffiliationName": "EBMT LWP Paris Office, H\u00f4pital Saint-Antoine"}, "55752409600": {"Name": "Finel H.", "AuthorID": "55752409600", "AffiliationID": "60009907", "AffiliationName": "EBMT LWP Paris Office, H\u00f4pital Saint-Antoine"}, "7005293399": {"Name": "Dreger P.", "AuthorID": "7005293399", "AffiliationID": "60016908", "AffiliationName": "Deptartment Medicine V, University of Heidelberg"}, "7004071645": {"Name": "Mohty M.", "AuthorID": "7004071645", "AffiliationID": "60009907", "AffiliationName": "Service d'H\u00e9matologie et Th\u00e9rapie Cellulaire, H\u00f4pital Saint Antoine"}, "7003572449": {"Name": "Castagna L.", "AuthorID": "7003572449", "AffiliationID": "60024876", "AffiliationName": "Department of Oncology and Haematology, Transplantation Unit, Istituto Clinico Humanitas"}, "35416735200": {"Name": "Peggs K.S.", "AuthorID": "35416735200", "AffiliationID": "60022148", "AffiliationName": "Department of Haematology, University College London Cancer Institute"}, "7103365695": {"Name": "Blaise D.", "AuthorID": "7103365695", "AffiliationID": "60028690, 60024899", "AffiliationName": "Programme de Transplantation & Therapie Cellulaire, Centre de Recherche en Canc\u00e9rologie de Marseille, Institut Paoli Calmettes"}, "6701426079": {"Name": "Afanasyev B.", "AuthorID": "6701426079", "AffiliationID": "60002685", "AffiliationName": "First State Pavlov Medical University of St. Petersburg, Raisa Gorbacheva Memorial Research Institute for Paediatric Oncology, Haematology, and Transplantation"}, "7003531511": {"Name": "Diez-Martin J.L.", "AuthorID": "7003531511", "AffiliationID": "60027282, 60033237, 60108393", "AffiliationName": "Department of Haematology, Instituto de investigaci\u00f3n sanitaria Gregorio Mara\u00f1on, Facultad de Medicina, Universidad Complutense Madrid, Hospital GU Gregorio Mara\u00f1on"}, "57220650341": {"Name": "Sierra J.", "AuthorID": "57220650341", "AffiliationID": "60009466", "AffiliationName": "Haematology Department, Hospital Santa Creu i Sant Pau"}, "12786149700": {"Name": "Bloor A.", "AuthorID": "12786149700", "AffiliationID": "60028784", "AffiliationName": "Christie NHS Trust Hospital, Adult Leukaemia and Bone Marrow Transplant Unit"}, "57207172255": {"Name": "Martinez C.", "AuthorID": "57207172255", "AffiliationID": "60030315", "AffiliationName": "Department of Haematology, Hospital Clinic, Institute of Haematology & Oncology"}, "8903082900": {"Name": "Robinson S.", "AuthorID": "8903082900", "AffiliationID": "60170515", "AffiliationName": "Bone Marrow Transplant Unit, University Hospital Bristol"}, "23976887800": {"Name": "Malladi R.", "AuthorID": "23976887800", "AffiliationID": "60012191", "AffiliationName": "Centre for Clinical Haematology, Queen Elizabeth Hospital"}, "56899805800": {"Name": "Corradini P.", "AuthorID": "56899805800", "AffiliationID": "60030318, 60006583", "AffiliationName": "Deptartment Haematology, IRCCS Istituto Nazionale dei Tumori, University of Milano"}, "8341482100": {"Name": "Montoto S.", "AuthorID": "8341482100", "AffiliationID": "60004093, 60159931", "AffiliationName": "Department of Haemato-Oncology, St Bartholomew's Hospital, Barts Health NHS Trust"}, "56148330700": {"Name": "Sureda A.", "AuthorID": "56148330700", "AffiliationID": "60005871, 60015633", "AffiliationName": "Department of Haematology, Institut Catala d'Oncologia, Hospital Duran I Reynals"}}}